Compare Kalbe Farma Tbk (KLBF) vs Solusi Bangun Indonesia Tbk. (SMCB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kalbe Farma Tbk vs Solusi Bangun Indonesia Tbk. — how do they compare? Kalbe Farma Tbk trades at Rp735 (market cap 35.34T, 108.3M 24h volume), while Solusi Bangun Indonesia Tbk. trades at Rp775 (market cap 6.99T). The key difference: Kalbe Farma Tbk is far larger — about 5.1× Solusi Bangun Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| KLBF | SMCB | |
|---|---|---|
Market Cap | 35.34T | 6.99T |
Volume | 108.3M | — |
Lot | 1.08M | — |
Turnover | 80.02B | — |
Average Price | 738.89 | — |
Value | 80.02B | — |
Indicative Equilibrium Price | 735 | — |
Indicative Equilibrium Volume | 59.74K | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Kalbe Farma Tbk
PT Kalbe Farma Tbk (the Company) was established in the Republic of Indonesia, within the framework of the Domestic Capital Investment Law No. 6 Year 1968, as amended by Law No. 12 Year 1970, basedon Notarial Deed No. 3 of Raden Imam Soesetyo Prawirokoesoemo datedon September 10th, 1966. The Company, which started commercial operation in 1966.
Read more on KLBF →About Solusi Bangun Indonesia Tbk.
PT Holcim Indonesia Tbk (the Company) was originally a joint venture between a subsidiary of Kaiser Cement and Gypsum Corp. and PT Semen Gresik. Founded in 1971, the company owns a factory in Narogong, West Java, with an annual capacity of 3 million tons. The Company changed its foreign capital investment status (PMA) to domestic capital investment (PMDN) based on the approval from Chairman of Capital Investment Coordinating Board No. 17/V/1988 dated November 19, 1988. Effective January 1, 2006, the Company changed its name from PT Semen Cibinong Tbk. to PT Holcim Indonesia Tbk.
Read more on SMCB →
